China Universal Asset Management »

Urogen Pharma shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $54k 3.6k 15.10
2023-09-30 $11k 774 14.21
2023-06-30 $3.0k 307 9.77
2023-03-31 $3.0k 313 9.58
2022-12-31 $2.0k 234 8.55
2022-09-30 $2.0k 213 9.39

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Vertex Pharmaceuticals Common Stock (VRTX)
Adobe Common Stock (ADBE)
Nvidia Corp Common Stock (NVDA)
Meta Platforms Inc-class A Common Stock (META)
Servicenow Common Stock (NOW)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Gilead Sciences Common Stock (GILD)
Tesla Common Stock (TSLA)
Visa Inc-class A Shares Common Stock (V)
Workday Inc-class A Common Stock (WDAY)
Alphabet Inc-cl A Common Stock (GOOGL)
Salesforce Common Stock (CRM)

View all positions for China Universal Asset Management

Top funds holding Urogen Pharma

RA Capital Management
Dr. Jeffrey R. Jay, M.D.
Credit Suisse
Harel Insurance Investments & Financial Services
Migdal Insurance & Financial Holdings
Millennium Management
Opaleye Management
Superstring Capital Management
Laurion Capital Management
Wells Fargo & Company
Citadel Advisors
Vanguard Group
ARK Investment Management
AlphaCentric Advisors
Schonfeld Strategic Advisors

View all funds holding Urogen Pharma